Skip to main content
Top
Published in: Archives of Women's Mental Health 1/2010

01-02-2010

DSM-V and reproductive-related psychiatric disorders: a closer look at windows of vulnerability

Author: Claudio N. Soares

Published in: Archives of Women's Mental Health | Issue 1/2010

Login to get access

Excerpt

As the discussions on how to reformulate the Diagnostic and Statistical Manual of Mental Disorders (DSM) approach a crucial moment, it would be pertinent to take a closer look at the predictive value and clinical significance of reproductive-related psychiatric events. As it stands in its current edition, the DSM fails to help clinicians and researchers to consider these events while conceptualizing clinical diagnoses or establishing therapeutic strategies for psychiatric disorders, particularly mood and anxiety disorders in women. Such omission is inconsistent with robust epidemiologic and clinical evidence gathered over the past decades that sub-populations of women present with a heightened susceptibility to develop mood disorders during periods of intense hormonal fluctuations such as the puerperal period or the menopausal transition. Based on accumulate evidence, some have hypothesized that sub-groups of women would be exposed to “windows of vulnerability” for depression throughout their lifespan (Rubinow et al. 1998; Bloch et al. 2000). The basic premise is that a heightened brain’s sensitivity to changes in levels of reproductive hormones—rather than exposure to absolute hormone levels (e.g., low estrogen concentrations)—could constitute the trigger for reproductive-related mood disorders. By recognizing the existence of these ‘windows’, the new DSM could not only promote a better conceptual framework and advance research on the biological underpinnings of mental disorders but also help clinicians to tailor clinical interventions for female-specific mood disorders with novel hormonal and non-hormonal strategies. …
Literature
go back to reference Bethea CL, Lu NZ, Gundlah C, Streicher JM (2002) Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23(1):41–100CrossRefPubMed Bethea CL, Lu NZ, Gundlah C, Streicher JM (2002) Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23(1):41–100CrossRefPubMed
go back to reference Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157(6):924–930CrossRefPubMed Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157(6):924–930CrossRefPubMed
go back to reference Joffe H, Soares CN, Petrillo LF, Viguera AC, Somley BL, Koch JK, Cohen LS (2007) Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. J Clin Psychiatry 68(6):943–950CrossRefPubMed Joffe H, Soares CN, Petrillo LF, Viguera AC, Somley BL, Koch JK, Cohen LS (2007) Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. J Clin Psychiatry 68(6):943–950CrossRefPubMed
go back to reference Kugaya A, Epperson CN, Zoghbi S et al (2003) Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 160(8):1522–1524CrossRefPubMed Kugaya A, Epperson CN, Zoghbi S et al (2003) Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 160(8):1522–1524CrossRefPubMed
go back to reference Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M (2004) Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 55(4):406–412CrossRefPubMed Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M (2004) Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 55(4):406–412CrossRefPubMed
go back to reference Payne JL, Klein SR, Zamoiski RB, Zandi PP, Bienvenu OJ, Mackinnon DF, Mondimore FM, Schweizer B, Swartz KL, Crowe RP, Scheftner WA, Weissman MM, Levinson DF, DePaulo JR Jr, Potash JB, NIMH Genetics Initiative Bipolar Disorder Consortium (2009) Premenstrual mood symptoms: study of familiality and personality correlates in mood disorder pedigrees. Arch Womens Ment Health 12(1):27–34CrossRefPubMed Payne JL, Klein SR, Zamoiski RB, Zandi PP, Bienvenu OJ, Mackinnon DF, Mondimore FM, Schweizer B, Swartz KL, Crowe RP, Scheftner WA, Weissman MM, Levinson DF, DePaulo JR Jr, Potash JB, NIMH Genetics Initiative Bipolar Disorder Consortium (2009) Premenstrual mood symptoms: study of familiality and personality correlates in mood disorder pedigrees. Arch Womens Ment Health 12(1):27–34CrossRefPubMed
go back to reference Rubinow DR, Schmidt PJ, Roca CA (1998) Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 44(9):839–850CrossRefPubMed Rubinow DR, Schmidt PJ, Roca CA (1998) Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 44(9):839–850CrossRefPubMed
go back to reference Schmidt PJ, Nieman L, Danaceau MA et al (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183(2):414–420CrossRefPubMed Schmidt PJ, Nieman L, Danaceau MA et al (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183(2):414–420CrossRefPubMed
go back to reference Soares CN, Almeida OP, Joffe H, Cohen LS (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58(6):529–534CrossRefPubMed Soares CN, Almeida OP, Joffe H, Cohen LS (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58(6):529–534CrossRefPubMed
go back to reference Soares CN, Poitras JR, Prouty J (2003) Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging 20(2):85–100CrossRefPubMed Soares CN, Poitras JR, Prouty J (2003) Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging 20(2):85–100CrossRefPubMed
go back to reference Stahl S (2001) Effects of estrogen on the central nervous system. JClin Psychiatry 62(5):317–318 Stahl S (2001) Effects of estrogen on the central nervous system. JClin Psychiatry 62(5):317–318
go back to reference Stahl M (2009) Vasomotor symptoms and depression in women, Part 1. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive disorder. J Clin Psychiatry 70(1):11–12CrossRefPubMed Stahl M (2009) Vasomotor symptoms and depression in women, Part 1. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive disorder. J Clin Psychiatry 70(1):11–12CrossRefPubMed
Metadata
Title
DSM-V and reproductive-related psychiatric disorders: a closer look at windows of vulnerability
Author
Claudio N. Soares
Publication date
01-02-2010
Publisher
Springer Vienna
Published in
Archives of Women's Mental Health / Issue 1/2010
Print ISSN: 1434-1816
Electronic ISSN: 1435-1102
DOI
https://doi.org/10.1007/s00737-009-0116-z

Other articles of this Issue 1/2010

Archives of Women's Mental Health 1/2010 Go to the issue